Predictive value of cervical cytokine, antimicrobial and microflora levels for pre-term birth in high-risk women.
Adolescent
Adult
Antimicrobial Cationic Peptides
/ analysis
Biomarkers
/ analysis
Cervix Uteri
/ immunology
Cytokines
/ analysis
DNA, Bacterial
/ isolation & purification
Enzyme-Linked Immunosorbent Assay
Female
Humans
Infant, Newborn
Microbiota
/ genetics
Placenta
/ immunology
Predictive Value of Tests
Pregnancy
Pregnancy Trimester, Second
/ immunology
Premature Birth
/ diagnosis
Prognosis
Prospective Studies
Real-Time Polymerase Chain Reaction
Young Adult
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
02 08 2019
02 08 2019
Historique:
received:
14
03
2019
accepted:
10
07
2019
entrez:
4
8
2019
pubmed:
4
8
2019
medline:
11
11
2020
Statut:
epublish
Résumé
Spontaneous preterm birth (sPTB, delivery <37 weeks gestation), accounts for approximately 10% of births worldwide; the aetiology is multifactorial with intra-amniotic infection being one contributing factor. This study aimed to determine whether asymptomatic women with a history of sPTB or cervical surgery have altered levels of inflammatory/antimicrobial mediators and/or microflora within cervical fluid at 22-24 weeks gestation. External cervical fluid was collected from women with history of previous sPTB and/or cervical surgery at 22-24 weeks gestation (n = 135). Cytokine and antimicrobial peptides were measured on a multiplex platform or by ELISA. qPCR was performed for detection of 7 potentially pathogenic bacterial species. IL-8 and IL-1β levels were lower in women who delivered preterm compared to those who delivered at term (IL-8 P = 0.02; IL-1β P = 0.04). There were no differences in elafin or human beta defensin-1 protein levels between the two groups. Multiple bacterial species were detected in a higher proportion of women who delivered preterm than in those who delivered at term (P = 0.005). Cervical fluid IL-8 and IL-1β and microflora have the potential to be used as biomarkers to predict sPTB in high risk women.
Identifiants
pubmed: 31375740
doi: 10.1038/s41598-019-47756-7
pii: 10.1038/s41598-019-47756-7
pmc: PMC6677789
doi:
Substances chimiques
Antimicrobial Cationic Peptides
0
Biomarkers
0
Cytokines
0
DNA, Bacterial
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
11246Subventions
Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : Wellcome Trust
ID : WT097228MA
Pays : United Kingdom
Références
Am J Respir Cell Mol Biol. 2009 Dec;41(6):696-704
pubmed: 19251943
Placenta. 2007 Feb-Mar;28(2-3):161-9
pubmed: 16513165
Am J Obstet Gynecol. 1996 Oct;175(4 Pt 1):812-7
pubmed: 8885727
Biomed Res Int. 2015;2015:645853
pubmed: 26078959
FEBS Lett. 1999 Jun 11;452(3):309-13
pubmed: 10386612
Proc Natl Acad Sci U S A. 2015 Sep 1;112(35):11060-5
pubmed: 26283357
Am J Obstet Gynecol. 2004 Oct;191(4):1331-8
pubmed: 15507962
Am J Obstet Gynecol. 2004 Oct;191(4):1324-30
pubmed: 15507961
Paediatr Perinat Epidemiol. 2001 Jul;15 Suppl 2:41-56
pubmed: 11520399
BMC Pregnancy Childbirth. 2012 Aug 06;12:79
pubmed: 22866909
Obstet Gynecol. 2009 Dec;114(6):1232-1238
pubmed: 19935024
Science. 2014 Aug 15;345(6198):760-5
pubmed: 25124429
Sci Transl Med. 2016 Aug 3;8(350):350ra102
pubmed: 27488896
BMJ. 2006 Apr 22;332(7547):937-9
pubmed: 16497733
PLoS One. 2014 Jul 30;9(7):e100771
pubmed: 25075964
Reprod Sci. 2009 Dec;16(12):1125-34
pubmed: 19723838
Infect Immun. 1996 Nov;64(11):4520-4
pubmed: 8890201
Am J Obstet Gynecol. 2003 Aug;189(2):560-7
pubmed: 14520234
Am J Obstet Gynecol. 2009 Apr;200(4):377.e1-4
pubmed: 19200941
Expert Rev Vaccines. 2010 Oct;9(10):1231-7
pubmed: 20923272
Am J Reprod Immunol. 2015 Aug;74(2):123-5
pubmed: 25773319
Lancet. 2016 May 21;387(10033):2106-2116
pubmed: 26921136
Am J Obstet Gynecol. 1998 May;178(5):1035-40
pubmed: 9609580
Am J Obstet Gynecol. 2003 Oct;189(4):1161-7
pubmed: 14586371
Am J Obstet Gynecol. 2003 Jul;189(1):139-47
pubmed: 12861153
PLoS One. 2012;7(12):e52412
pubmed: 23300664
Placenta. 2007 Nov-Dec;28(11-12):1099-106
pubmed: 17664005
J Matern Fetal Neonatal Med. 2014 Jul;27(10):1015-9
pubmed: 24228627
Natl Vital Stat Rep. 2004 Nov 24;53(10):1-29
pubmed: 15622996
Am J Obstet Gynecol. 1992 Oct;167(4 Pt 1):1086-91
pubmed: 1415396
J Clin Microbiol. 2009 Jan;47(1):38-47
pubmed: 18971361
Mol Hum Reprod. 2005 Oct;11(10):761-6
pubmed: 16254004
BMJ. 2002 Aug 10;325(7359):301
pubmed: 12169504
J Clin Microbiol. 2006 Jan;44(1):51-5
pubmed: 16390947
Eur J Obstet Gynecol Reprod Biol. 2012 Nov;165(1):33-6
pubmed: 22884587
J Reprod Immunol. 2007 Aug;75(1):48-55
pubmed: 17275097
Am J Obstet Gynecol. 2005 Nov;193(5):1663-9
pubmed: 16260207
Acta Obstet Gynecol Scand. 2001 Jun;80(6):546-51
pubmed: 11380291
Pediatr Dev Pathol. 2003 Sep-Oct;6(5):435-48
pubmed: 14708737
Pediatr Dev Pathol. 2004 May-Jun;7(3):237-49
pubmed: 15022063
Arch Gynecol Obstet. 2010 May;281(5):793-9
pubmed: 19554343
N Engl J Med. 2000 May 18;342(20):1500-7
pubmed: 10816189
Acta Obstet Gynecol Scand. 2002 Aug;81(8):706-12
pubmed: 12174153
Arch Pathol Lab Med. 2013 May;137(5):706-20
pubmed: 23627456
Am J Obstet Gynecol. 2006 Jan;194(1):14-9
pubmed: 16389005
Am J Obstet Gynecol. 2001 Nov;185(5):1130-6
pubmed: 11717646
Ultrasound Obstet Gynecol. 1998 Aug;12(2):86-92
pubmed: 9744050
Ultrasound Obstet Gynecol. 2016 Feb;47(2):210-6
pubmed: 25964191
PLoS One. 2009 Dec 08;4(12):e8205
pubmed: 19997613
Am J Obstet Gynecol. 2001 Feb;184(3):483-8
pubmed: 11228507
Am J Obstet Gynecol. 2007 Jun;196(6):576.e1-6; discussion 576.e6-7
pubmed: 17547902
J Immunol Methods. 2006 Feb 20;309(1-2):205-8
pubmed: 16436279
Am J Reprod Immunol. 2005 Aug;54(2):70-6
pubmed: 16105098
J Cell Biol. 1991 Jun;113(5):981-6
pubmed: 2040651
Obstet Gynecol. 2013 Aug;122(2 Pt 1):283-289
pubmed: 23969796
J Perinat Med. 2004;32(4):323-6
pubmed: 15346817
Lancet. 2008 Jan 5;371(9606):75-84
pubmed: 18177778